About
About Veru
Our Scientific Efforts
Management Team
Board of Directors
Scientific Advisory Board
Publications & Meeting Presentations
Pipeline
Cardiometabolic Obesity Drug Program
Cardiometabolic Inflammation Atherosclerosis Program
Investors
Investors
Investor Kit
Press Releases
Stock Information
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Investor Presentations
Corporate Governance
Letter to Shareholders
Board Committees
Governance Documents
Policy for Director Attendance and for Shareholder Communications with Directors
News
Veru Press Releases
Veru in the News
Contact
Search for:
IR Calendar
Investors
Investors
Investor Kit
News & Events
Overview
Press Releases
IR Calendar
Presentations
Email Alerts
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
IRS Form 8937
Stock Data
Quote
Charts
Historical Data
Ratios
SEC Filings
Overview
All SEC Filings
Annual Reports & Proxy Statements
Quarterly Reports
Section 16 Filings
Governance
Overview
Board Committees
Governance Documents
Letter to Shareholders
Policy for Director Attendance and for Shareholder Communications with Directors
2nd Annual GLP-1-Based Therapeutics Summit
Boston, Massachusetts
Apr 29 – May 1, 2025
Email Alerts
Contacts
RSS News Feed
Go to Top
